NM
NOUGUES MAXIMO F Chief Financial Officer
CFO M
US US · SEC (Form 4)
Discover the full record of transactions filed by NOUGUES MAXIMO F, Chief Financial Officer. Officer active across 1 companies, notably Puma Biotechnology, INC.. In total, 25 filings have been recorded. Total volume traded: €59k. The latest transaction was filed on 2 June 2022 — Cession. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations 25 total
€290 162 shares @ €1.7875 0.0001% mcap 0.5% of flow
Common Stock
SEC:0001437749-22-014434:0 · 2 Jun 2022
€367 165 shares @ €2.2226 0.0001% mcap 0.6% of flow
Common Stock
SEC:0001437749-22-010926:0 · 3 May 2022
€578 206 shares @ €2.8043 0.0002% mcap 1.0% of flow
Common Stock
SEC:0001437749-22-008328:0 · 4 Apr 2022
062,176 shares 0
Common Stock
SEC:0001437749-22-006188:0 · 3 Mar 2022
€343 169 shares @ €2.0318 0.0001% mcap 0.6% of flow
Common Stock
SEC:0001437749-22-005306:0 · 2 Mar 2022
€438 199 shares @ €2.2017 0.0001% mcap 1.6% of flow
Common Stock
SEC:0001437749-22-002412 · 2 Feb 2022
€438 199 shares @ €2.2017 0.0001% mcap 0.7% of flow
Common Stock
SEC:0001437749-22-002412:0 · 2 Feb 2022
€20,988 7,484 shares @ €2.8044 0.0060% mcap 75.0% of flow
Common Stock
SEC:0001437749-22-000444 · 3 Jan 2022
€20,988 7,484 shares @ €2.8044 0.0060% mcap 35.7% of flow
Common Stock
SEC:0001437749-22-000444:0 · 3 Jan 2022
€422 162 shares @ €2.6061 0.0001% mcap 1.5% of flow
Common Stock
SEC:0001437749-21-027954 · 2 Dec 2021
€422 162 shares @ €2.6061 0.0001% mcap 0.7% of flow
Common Stock
SEC:0001437749-21-027954:0 · 2 Dec 2021
€763 156 shares @ €4.889 0.0002% mcap 2.7% of flow
Common Stock
SEC:0001209191-21-062788 · 2 Nov 2021
€763 156 shares @ €4.889 0.0002% mcap 1.3% of flow
Common Stock
SEC:0001209191-21-062788:0 · 2 Nov 2021
€859 161 shares @ €5.3364 0.0002% mcap 3.1% of flow
Common Stock
SEC:0001437749-21-023380 · 4 Oct 2021
€859 161 shares @ €5.3364 0.0002% mcap 1.5% of flow
Common Stock
SEC:0001437749-21-023380:0 · 4 Oct 2021
€980 155 shares @ €6.3243 0.0003% mcap 3.5% of flow
COMMON STOCK
SEC:0001209191-21-054896 · 2 Sept 2021
€980 155 shares @ €6.3243 0.0003% mcap 1.7% of flow
COMMON STOCK
SEC:0001209191-21-054896:0 · 2 Sept 2021
€978 154 shares @ €6.3514 0.0003% mcap 3.5% of flow
COMMON STOCK
SEC:0001209191-21-049435 · 2 Aug 2021
€978 154 shares @ €6.3514 0.0003% mcap 1.7% of flow
COMMON STOCK
SEC:0001209191-21-049435:0 · 2 Aug 2021
€1,211 155 shares @ €7.8158 0.0003% mcap 4.3% of flow
COMMON STOCK
SEC:0001209191-21-045599 · 2 Jul 2021
€1,211 155 shares @ €7.8158 0.0003% mcap 2.1% of flow
COMMON STOCK
SEC:0001209191-21-045599:0 · 2 Jul 2021
€1,337 152 shares @ €8.797 0.0004% mcap 4.8% of flow
COMMON STOCK
SEC:0001209191-21-038294 · 2 Jun 2021
€1,337 152 shares @ €8.797 0.0004% mcap 2.3% of flow
COMMON STOCK
SEC:0001209191-21-038294:0 · 2 Jun 2021
152 shares
COMMON STOCK
SEC:0001209191-21-030355 · 3 May 2021
€1,249 152 shares @ €8.2167 0.0004% mcap 2.1% of flow
COMMON STOCK
SEC:0001209191-21-030355:0 · 3 May 2021
About NOUGUES MAXIMO F Maximo F. Nougues is the Chief Financial Officer of PUMA Biotechnology, Inc.